Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants

Rinn, 2012, Genome regulation by long noncoding RNAs, Annu. Rev. Biochem., 81, 145, 10.1146/annurev-biochem-051410-092902 Kapusta, 2014, Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications, Trends Genet., 30, 439, 10.1016/j.tig.2014.08.004 Liu, 2013, A meta-analysis of the genomic and transcriptomic composition of complex life, Cell Cycle, 12, 2061, 10.4161/cc.25134 Morris, 2014, The rise of regulatory RNA, Nat. Rev. Genet., 15, 423, 10.1038/nrg3722 Pascual, 2010, A genomic approach to human autoimmune diseases, Annu. Rev. Immunol., 28, 535, 10.1146/annurev-immunol-030409-101221 Hangauer, 2013, Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs, Plos Genet., 9 Jensen, 2013, Dealing with pervasive transcription, Mol. Cell, 52, 473, 10.1016/j.molcel.2013.10.032 Li, 2016, Enhancers as non-coding RNA transcription units: recent insights and future perspectives, Nat. Rev. Genet., 17, 207, 10.1038/nrg.2016.4 Kumar, 2013, Human disease-associated genetic variation impacts large intergenic non-coding RNA expression, Plos Genet., 9, 10.1371/journal.pgen.1003201 Vahedi, 2015, Super-enhancers delineate disease-associated regulatory nodes in T cells, Nature, 520, 10.1038/nature14154 Corradin, 2016, Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry, Nat. Genet., 48, 1313, 10.1038/ng.3674 Quang, 2015, Motif signatures in stretch enhancers are enriched for disease-associated genetic variants, Epigenet Chromatin, 8, 10.1186/s13072-015-0015-7 Mells, 2015, Making the most of new genetic risk factors - genetic and epigenetic fine mapping of causal autoimmune disease variants, Clin. Res. Hepatol. Gas., 39, 408, 10.1016/j.clinre.2015.05.002 Farh, 2015, Genetic and epigenetic fine mapping of causal autoimmune disease variants, Nature, 518, 337, 10.1038/nature13835 Ricano-Ponce, 2013, Mapping of immune-mediated disease genes, Annu. Rev. Genom Hum. G., 14, 325, 10.1146/annurev-genom-091212-153450 Maurano, 2012, Systematic localization of common disease-associated variation in regulatory DNA, Science, 337, 1190, 10.1126/science.1222794 Hnisz, 2013, Super-enhancers in the control of cell identity and disease, Cell, 155, 934, 10.1016/j.cell.2013.09.053 Guo, 2014, Three-stage quality control strategies for DNA re-sequencing data, Brief. Bioinform., 15, 879, 10.1093/bib/bbt069 Guo, 2014, Multi-perspective quality control of Illumina exome sequencing data using QC3, Genomics, 103, 323, 10.1016/j.ygeno.2014.03.006 Guo, 2014, MultiRankSeq: multiperspective approach for RNAseq differential expression analysis and quality control, Biomed. Res. Int., 2014, 10.1155/2014/248090 Kim, 2013, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol., 14, R36, 10.1186/gb-2013-14-4-r36 Trapnell, 2012, Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks, Nat. Protoc., 7, 562, 10.1038/nprot.2012.016 Anders, 2010, Differential expression analysis for sequence count data, Genome Biol., 11, R106, 10.1186/gb-2010-11-10-r106 Spurlock, 2015, Expression and functions of long noncoding RNAs during human T helper cell differentiation, Nat. Commun., 6 McLean, 2010, GREAT improves functional interpretation of cis-regulatory regions, Nat. Biotechnol., 28, 10.1038/nbt.1630 McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis, Ann. Neurol., 50, 121, 10.1002/ana.1032 Lennardjones, 1989, Classification of inflammatory bowel-disease, Scand. J. Gastroenterol., 24, 2, 10.3109/00365528909091339 Storek, 2004, Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases), Clin. Immunol., 113, 285, 10.1016/j.clim.2004.07.006 Schulze-Koops, 2004, Lymphopenia and autoimmune diseases, Arthritis Res. Ther., 6, 178, 10.1186/ar1208 Benjamini, 2010, Discovering the false discovery rate, J. R. Stat. Soc. B, 72, 405, 10.1111/j.1467-9868.2010.00746.x Natoli, 2012, Noncoding transcription at enhancers: general principles and functional models, Annu. Rev. Genet., 46, 1, 10.1146/annurev-genet-110711-155459 Hindorff, 2009, Potential etiologic and functional implications of genome-wide association loci for human diseases and traits, P Natl. Acad. Sci. U. S. A., 106, 9362, 10.1073/pnas.0903103106 Peeters, 2015, Inhibition of super-enhancer activity in autoinflammatory site-derived T cells reduces disease-associated gene expression, Cell Rep., 12, 1986, 10.1016/j.celrep.2015.08.046 Cronstein, 2005, Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis, Pharmacol. Rev., 57, 163, 10.1124/pr.57.2.3 Spurlock, 2012, Methotrexate increases expression of cell cycle checkpoint genes via JNK activation, Arthritis Rheum-Us, 64, 1780, 10.1002/art.34342 Spurlock, 2014, Methotrexate inhibits NF-kappa B activity via long intergenic (noncoding) RNA-p21 induction, Arthritis Rheumatol., 66, 2947, 10.1002/art.38805 Altshuler, 2005, A haplotype map of the human genome, Nature, 437, 1299, 10.1038/nature04226 Bayliss, 2016, Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas, J. Neuropath Exp. Neur, 75 Cooper, 2009, Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases, J. Autoimmun., 33, 197, 10.1016/j.jaut.2009.09.008 Clauw, 2014, Fibromyalgia a clinical review, Jama J Am. Med. Assoc., 311, 1547, 10.1001/jama.2014.3266 Makker, 2015, Genetic epidemiology of irritable bowel syndrome, World J. Gastroenterol., 21, 11353, 10.3748/wjg.v21.i40.11353